Literature DB >> 23314769

Nonthermal irreversible electroporation: fundamentals, applications, and challenges.

Alexander Golberg1, Martin L Yarmush.   

Abstract

Tissue ablation is an essential procedure for the treatment of many diseases. In the last decade, a nonthermal tissue ablation using intensive pulsed electric fields, called nonthermal irreversible electroporation (NTIRE), has rapidly emerged. The exact mechanisms responsible for cell death by NTIRE, however, are currently unknown. Nevertheless, the technique's remarkable ability to ablate tissue in the proximity of larger blood vessels, to preserve tissue architecture, short procedure duration, and shortened postoperative recovery period rapidly moved NTIRE from bench to bed side. This work provides an overview on the development of NTIRE, its current state-of-the-art, challenges, and future needs.

Mesh:

Year:  2013        PMID: 23314769     DOI: 10.1109/TBME.2013.2238672

Source DB:  PubMed          Journal:  IEEE Trans Biomed Eng        ISSN: 0018-9294            Impact factor:   4.538


  51 in total

Review 1.  Strategies to target drugs to gliomas and CNS metastases of solid tumors.

Authors:  B Milojkovic Kerklaan; O van Tellingen; A D R Huitema; J H Beijnen; W Boogerd; J H M Schellens; D Brandsma
Journal:  J Neurol       Date:  2015-10-17       Impact factor: 4.849

2.  Measuring the potential energy barrier to lipid bilayer electroporation.

Authors:  Jason T Sengel; Mark I Wallace
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-08-05       Impact factor: 6.237

Review 3.  Cytoreduction for colorectal metastases: liver, lung, peritoneum, lymph nodes, bone, brain. When does it palliate, prolong survival, and potentially cure?

Authors:  Camille L Stewart; Susanne Warner; Kaori Ito; Mustafa Raoof; Geena X Wu; Jonathan Kessler; Jae Y Kim; Yuman Fong
Journal:  Curr Probl Surg       Date:  2018-10-04       Impact factor: 1.909

4.  Successful ablation of lymph nodes using irreversible electroporation (IRE) in a porcine survival model.

Authors:  Stefan Fritz; Christof M Sommer; Thomas Longerich; Clemens Kuhn-Neureuther; Boris Radeleff; Jens Werner; Thilo Hackert
Journal:  Langenbecks Arch Surg       Date:  2017-04-04       Impact factor: 3.445

5.  EUS-guided irreversible electroporation using endoscopic needle-electrode in porcine pancreas.

Authors:  Jae Min Lee; Hyuk Soon Choi; Hoon Jai Chun; Eun Sun Kim; Bora Keum; Yeon Seok Seo; Yoon Tae Jeen; Hong Sik Lee; Soon Ho Um; Chang Duck Kim; Hong Bae Kim
Journal:  Surg Endosc       Date:  2018-10-29       Impact factor: 4.584

6.  Skin regeneration with all accessory organs following ablation with irreversible electroporation.

Authors:  Alexander Golberg; Martin Villiger; G Felix Broelsch; Kyle P Quinn; Hassan Albadawi; Saiqa Khan; Michael T Watkins; Irene Georgakoudi; William G Austen; Marianna Bei; Brett E Bouma; Martin C Mihm; Martin L Yarmush
Journal:  J Tissue Eng Regen Med       Date:  2017-05-23       Impact factor: 3.963

7.  Imaging the dynamics of individual electropores.

Authors:  Jason T Sengel; Mark I Wallace
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-25       Impact factor: 11.205

8.  Dielectrophoresis study of temporal change in internal conductivity of single CHO cells after electroporation by pulsed electric fields.

Authors:  E Salimi; K Braasch; M Butler; D J Thomson; G E Bridges
Journal:  Biomicrofluidics       Date:  2017-02-13       Impact factor: 2.800

9.  Non-thermal, pulsed electric field cell ablation: A novel tool for regenerative medicine and scarless skin regeneration.

Authors:  Alexander Golberg; G Felix Broelsch; Stefan Bohr; Martin C Mihm; William G Austen; Hassan Albadawi; Michael T Watkins; Martin L Yarmush
Journal:  Technology (Singap World Sci)       Date:  2013-09

10.  Eradication of multidrug-resistant pseudomonas biofilm with pulsed electric fields.

Authors:  Gaddi Blumrosen; Daniela Vecchio; Saiqa I Khan; Alexander Golberg; Michael C McCormack; Martin L Yarmush; Michael R Hamblin; William G Austen
Journal:  Biotechnol Bioeng       Date:  2015-09-09       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.